NEW YORK, Jan. 2, 2015 /PRNewswire/ -- Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the District of New Jersey on behalf of investors who
purchased Nymox Pharmaceutical Corporation ("Nymox" or the
"Company") (Nasdaq: NYMX) securities between January 31, 2011 and November 2, 2014.
For more information, click here:
http://zlk.9nl.com/nymox-pharmaceutical-nymx.
The complaint alleges that Nymox failed to disclose material
information affecting the Phase 3 clinical trials for it's
proprietary drug NX-1207 for the treatment of benign prostatic
hyperplastic (BPH).
On November 2, 2014, Nymox
disclosed that the Company's two Phase 3 studies had to be halted
because the drug failed to meet its primary endpoints for efficacy.
The following day, Nymox disclosed to the market for the first
time, among other things, the difficulties faced in enrolling men
for the trials, and the subjective nature of the measurement of the
drug's success.
If you suffered a loss in Nymox you have until January 26, 2015 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit
http://zlk.9nl.com/nymox-pharmaceutical-nymx.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits and have helped shareholders
recover millions of dollars in losses over the years. For more
information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY
10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-notifies-investors-of-class-action-against-nymox-pharmaceutical-corporation-and-its-board-of-directors-and-a-lead-plaintiff-deadline-of-january-26-2015----nymx-300015111.html
SOURCE Levi & Korsinsky, LLP